Table 1. Summary of GWA scan and replication studies for 4 SNPs consistent in three stages.
SNP | Study | Casesb | Controlsb | MAFc | ORadd | Padd | P–Qd | |
---|---|---|---|---|---|---|---|---|
Cases | Controls | (95% CI) | ||||||
rs12522693 | GWAS | 16/242/673 | 13/172/780 | 0.15 | 0.10 | 1.55(1.27–1.89) | 1.86 × 10−5 | |
5q23.3 | Replication I | 34/404/1321 | 21/367/1487 | 0.13 | 0.11 | 1.27(1.10–1.46) | 1.10 × 10−3 | |
G/Aa | Replication II | 16/212/715 | 18/360/1460 | 0.13 | 0.11 | 1.23(1.04–1.46) | 1.61 × 10−2 | |
Combined All | 1.31(1.19–1.45) | 2.08 × 10−8 | 0.19 | |||||
rs10035791 | GWAS | 23/272/635 | 17/208/740 | 0.17 | 0.13 | 1.51(1.25–1.82) | 1.54 × 10−5 | |
5q23.3 | Replication I | 42/463/1249 | 33/442/1386 | 0.16 | 0.14 | 1.17(1.03–1.33) | 1.98 × 10−2 | |
G/Aa | Replication II | 23/252/668 | 31/433/1366 | 0.16 | 0.14 | 1.20(1.03–1.41) | 2.10 × 10−2 | |
Combined All | 1.25(1.14–1.36) | 8.20 × 10−7 | 0.08 | |||||
rs80007597 | GWAS | 13/230/688 | 9/162/793 | 0.14 | 0.09 | 1.59(1.29–1.96) | 1.16 × 10−5 | |
5q23.3 | Replication I | 27/386/1335 | 19/346/1493 | 0.13 | 0.10 | 1.25(1.08–1.45) | 2.73 × 10−5 | |
G/Ca | Replication II | 14/201/726 | 29/329/1475 | 0.12 | 0.11 | 1.17(0.98–1.39) | 7.64 × 10−2 | |
Combined All | 1.29(1.17–1.42) | 3.63 × 10−7 | 0.07 | |||||
rs17836917 | GWAS | 6/130/796 | 21/179/765 | 0.08 | 0.11 | 0.64(0.51–0.80) | 6.15 × 10−5 | |
17q12 | Replication I | 12/308/1439 | 34/371/1470 | 0.09 | 0.12 | 0.79(0.68–0.92) | 1.80 × 10−3 | |
G/Aa | Replication II | 7/159/777 | 21/379/1438 | 0.09 | 0.11 | 0.78(0.65–0.94) | 9.43 × 10−3 | |
Combined All | 0.75(0.68–0.83) | 4.55 × 10−8 | 0.27 |
Major/minor alleles
Variant homozygote/Heterozygote/Wild type homozygote
Minor allele frequency (MAF)
ORadd, Padd: calculated by additive model adjusted for age, gender and first ten PC
P value of Cochran's Q test.